We discuss many of these risks in greater detail under the heading Risk Factors in the quarterly and annual reports that we file with the Securities and Exchange Commission (SEC). Forward-looking statements are not guarantees of future performance and our actual results of operations, financial condition and liquidity, and the development of the industry in which we operate may differ materially from the forward-looking statements contained in this press release. Any forward-looking statements that we make in this press release speak only as of the date of this press release. We assume no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. Non-GAAP Financial Measures To supplement our financial statements, which are prepared and presented in accordance with GAAP, we use the following non-GAAP financial measures, some of which are discussed above: adjusted net loss, adjusted operating expenses, adjusted research and development expenses, adjusted general and administrative expenses, adjusted other income (expense) and adjusted net loss per share. We believe these non-GAAP financial measures provide investors with useful supplemental information about the financial performance of our business, enable comparison of financial results between periods where certain items may vary independent of business performance, and allow for greater transparency with respect to key metrics used by management in operating our business. The presentation of these financial measures is not intended to be considered in isolation from, or as a substitute for, financial information prepared and presented in accordance with GAAP. Investors are cautioned that there are material limitations associated with the use of non-GAAP financial measures as an analytical tool. In particular, the adjustments to our GAAP financial measures reflect the exclusion of non-cash stock-based compensation expense, which is recurring and will be reflected in our financial results for the foreseeable future.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/aerie-pharmaceuticals-reports-third-quarter-200100673.html
This filter is located at the junction of the clear cornea and white sclera the whitish fibrous membrane albuginea which with the cornea forms the outer covering and protection of the eyeball. http://www.expertselfpublishing.com/alexanderreynoldstown/2016/11/01/simple-tips-on-finding-fundamental-aspects-of-astigmatism/However, one may suffer from sore eyeball to touch and cannot pin point the exact reason behind the eye pain. While short-term usage of this drug is unlikely to cause any serious side effects, the same cannot be said about the long-term use of prednisone. Due to sudden increase of GOP, the person suffering from closed angle glaucoma feels acute pain in the eyes, nausea and blurred vision. no dataThose who are using eye drops with prostaglandin analogy might see changes in eye colon and experience symptoms such as blurred vision, redness, burning, itching, and change in eyelid skin. Closed angle glaucoma is associated with the blockage present at the iris and cornea joint. Ocular pain is the type of eye pain that occurs in the outer eye structures, like a sore eyelid. This article will give you information on the causes and treatment methods for eye itchiness. In case of closed angle glaucoma, it can be 40-80mm Hg. This swelling may be accompanied by severe pain and discomfort. A dog suffering from an eye infection will show several symptoms that can affect one or both the eyes. Eyes should be taken care of the most, as they mediate in our vision of the outside world. They may suffer from several visual impairments and even go blind as they grow old.